EGFR and neoplasm: Although the mechanism related to miR-320 resistance is still unclear, it was also found that target genes of miR-320 were involved in tumor progression and cell cycle progression, as well as the MAPK and ErbB signaling pathways, which can promote chemoresistance to cisplatin [60,98].